Michel Belley

The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs

Mark Abramovitz, Mohammed Adam, Yves Boie et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2000 · 557 citations · Full text

Life Sciences, Biochemistry, Pharmacology +10

Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D₄ receptor antagonist

Thomas R. Jones, Robert Zamboni, Michel Belley et al. · Canadian Journal of Physiology and Pharmacology · 1989 · 271 citations

Medicine, Pharmacology, Biochemical Pharmacology +9

Pharmacology of montelukast sodium (Singulair™), a potent and selective leukotriene D₄receptor antagonist

Thomas R. Jones, Marc Labelle, Michel Belley et al. · Canadian Journal of Physiology and Pharmacology · 1995 · 251 citations

Medicine, Pharmacology, Cellular Pharmacology +10

γ-Aminobutyric Acid Type B Receptors with Specific Heterodimer Composition and Postsynaptic Actions in Hippocampal Neurons Are Targets of Anticonvulsant Gabapentin Action

Gordon Ng, Sandrine S. Bertrand, Richard Sullivan et al. · Molecular Pharmacology · 2001 · 143 citations

Life Sciences, Neuroscience, Pharmacology +17

From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors

W. Cameron Black, Christopher I. Bayly, Michel Belley et al. · Bioorganic & Medicinal Chemistry Letters · 1996 · 108 citations

Medicine, Medicinal Chemistry, Pharmacology +10